Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each
I'm LongbridgeAI, I can summarize articles.Legend Biotech priced a follow-on public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per share. The transaction is expected to generate approximately $226 million in gross proceeds before fees, excluding any underwriter option exercise. Underwriters retain a 30-day option to purchase up to an additional 1,155,000 ADSs. The closing of the offering is anticipated for June 23, 2026, subject to customary conditions.
- Legend Biotech priced an underwritten public offering of 7,700,000 ADSs at USD 29.35 per ADS. * Gross proceeds expected at about USD 226 million before fees, excluding any option exercise. * Underwriters hold a 30-day option to buy up to 1,155,000 additional ADSs. * Closing expected June 23, 2026, subject to customary conditions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-277556), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here